Navigere Competitors and Similar CompaniesClear all

Aspira Women's Health's competitors and similar companies include Interpace Diagnostics.
Aspira Women's Health
Aspira Women's Health
Vermillion develops and commercializesdiagnostic teststhat address unmet needs in gynecologic oncology and womens health.
Interpace Diagnostics
Interpace Diagnostics
Interpace Diagnostics is a health care commercialization company providing insight-driven, integrated multi-channel message delivery for health care companies.
Founding Date
Founding Date
1993
Founding Date
1987
Type
Type
Public
Type
Public
Tags
Locations
Locations
Austin, US HQ
Locations
Parsippany-Troy Hills, US HQ
Morrisville, US
Pittsburgh, US
Employees
Employees
4310% increase
Employees
8919% increase
Valuation ($)
Valuation ($)
15.1 m
Valuation ($)
11.5 m

Financial

Revenue (est.)
Revenue (est.)
$343k (FY, 2025)
Revenue (est.)
$38.7m (FY, 2025)
Cost of goods
Cost of goods
$3.3m (FY, 2025)
Cost of goods
$14.6m (FY, 2025)
Gross profit
Gross profit
$5.9m (FY, 2025)
Gross profit
$24.1m (FY, 2025)
Net income
Net income
($12.8m) (FY, 2025)
Net income
$24.6m (FY, 2025)
For sources of this data, please see the company profile

View Company Profiles

Interpace Diagnostics
HQ
Parsippany-Troy Hills, US
Employees
89↑ 19% increase

Interpace Diagnostics is a health care commercialization company providing insight-driven, integrated multi-channel message delivery for health care companies.

View company